By Yantoultra Ngui SINGAPORE, July 13 (Reuters) - Mylan Inc, part of a global healthcare company Viatris, plans to sell up to ...

Mylan, part of Viatris, exits Biocon by selling its 5.64% stake for ₹3,679 crore. Domestic mutual funds and global investors ...

Mylan Inc. has divested its entire stake of upto 5.64% in Biocon Limited on the screen-based trading platform of the BSE ...

As many as 9.2 crore shares, representing a 5.64 percent stake in Biocon, changed hands in the pre-open block deal window at ...

ICICI Prudential Mutual Fund was the largest buyer among 36 investors, picking up 3.68 crore equity shares (2.26 percent ...

Mylan, part of global healthcare company Viatris, plans to sell up to 92 million shares in Biocon through a secondary ...

Viatris-owned Mylan looks to sell its entire 5.64% stake in Biocon through a block deal at a floor price of ₹378.50 per share ...

Singapore: Mylan Inc, ​part of a global healthcare ​company Viatris, plans to sell up to 92 million shares in Indian ...

Viatris-owned Mylan is looking to sell part of its 5.64% stake in Biocon through a block deal in the next seven to eight days ...